SYRE FY 2022 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SYRESpyre Therapeutics, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-87.6% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$85M-3640.2% margin

Net Income

-$84M-3598.8% margin

EPS (Diluted)

$-24.86

Cash Flow

Operating Cash Flow

-$80M

Free Cash Flow

-$80M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$71M

Total Liabilities

$21M

Stockholders' Equity

$50M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$19M	-87.6%
Gross Profit	$2M	$19M	-87.6%
Operating Income	-$85M	-$66M	-29.1%
Net Income	-$84M	-$66M	-27.4%